97% of our listeners don't realise they aren't followed, please double check, thank you!
The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
In this Episode, our guest is Dr. Behzad Kharabi, a consultant and CMO of multiple biotechs. At present, Dr Kharabi is the Medical Advisor at MaaT Pharma, the leading microbiome company in oncology, and has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Behzad is also the CMO at Tigen, a clinical-stage biotech company in the field of cell therapies to cure cancer.. Dr. Kharabi has founded his own clinical consulting company - Kharabi Consulting, aiming to provide the highest quality of clinical development support. We discuss Behzad’s profound career beginnings, and then move into topics around becoming a successful biotech and the key lessons Behzad learnt to get to where he is today.
Dr. Kharabi unveils a mix of stories and insights, including discussions about biotech success and failure, communicating with investors, recruitment in life sciences, how AI is being using in drug development, recent oncology discovery and more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Antonella Chadha: Founder @ Women's Brain Foundation, TED Speaker, Medical Doctor and Neuroscientist
Season 1 · Episode 2
Friday, February 14, 2025 • Duration 50:56
In this episode, our guest is Dr. Antonella Santuccione Chadha, globally recognised founder of the Women’s Brain Foundation, TED speaker, medical doctor and neuroscientist. Dr. Chadha is also a fractional CMO in Neurology & Medtech, as well as an Advisor to ReconnectLAB, Bottneuro, and EQUAL CARE. We discuss how Antonella paved her way from being a medical doctor to a Biotech Leader, and Antonella gives insights and advice to people wanting to become successful in the life science industry. We then delve into AI, where Dr. Chadha provides some super interesting thoughts of how AI will shape Drug Development in the future.
Dr. Chadha delivers a combination of advice and stories, including discussion on Regulation vs Drug Development, delegation, Antonella’s experience at TEDx, AI becoming Doctors, Alzheimer’s, the Women’s Brain Foundation, Medical Affairs and Clinical development working hand in hand and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
In this episode, our guest is Dr. Ingmar Bruns, M.D., Ph.D., a pioneer in biotech leadership and hematologist/oncologist. Dr Bruns is the Executive VP and CMO at Trillium Therapeutics Inc., a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We discuss Ingmar's breadth of experience in academia, where he studied medicine at both the Medical University of Vienna, as well as the Universität zu Lübeck, He then spent many years at both the University of Düsseldorf and the Albert Einstein College of Medicine.
We discuss a variety of topics including Ingmar’s successes and mistakes, drug development, golden rules for biotechs, as well as fundraising in the life science industry. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Christophe Giot: Clinical Cardiologist, Transitioning to Industry & AI in Pharma
Season 1 · Episode 4
Friday, February 28, 2025 • Duration 23:11
In this episode, our episode is Dr. Christophe Giot, a highly accomplished global executive with a foundation as a clinical cardiologist and extensive experience in Clinical and Medical Affairs across diverse therapeutic areas including cardiology (interventional cardiology, structural heart), vascular diseases, interventional oncology, urology, immunology, and rare diseases. Dr. Giot is the CMO and VP Clinical Affairs at Affluent Medical, and attended Université libre de Bruxelles to study Cardiology and become a MD. We discuss how Christophe kick-started his career in the Life Science Industry, before transitioning to Pharma, as well as the key achievements and milestones he made along the way.
Dr. Christophe Giot delivers a combination of stories and insights, including discussion on soft skills, communicating with investors, team building, AI in Pharma, the power of networking, onboarding, and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Michael Tusche: Biotech Leadership, Wall Street Investment & AI-Driven Drug Development
Season 1 · Episode 3
Friday, February 21, 2025 • Duration 46:54
In this Episode, our guest is Dr. Michael Tusche, Ph.D., M.B.A, a visionary biotech leader and seasoned investor in the space. Dr. Tusche is also the CEO of 3io Therapeutics, a biotechnology company focused on the development and commercialization of the next generation of viral immunotherapies for cancer. Dr. Tusche is also the Co-Founder and current Board Director at Nirsum Labs, a biotechnology company inventing and developing new medications for opioid use disorder (OUD). We discuss how Michael began his career, from his academia spanning a number of years at the University of Victoria as well as the University of Toronto, to then moving into industry. We then move into a discussion on investing into biotechs, and Dr. Tusche provides insight on how to become a successful biotech leader, with interesting stories and optimisation tips.
Dr. Tusche reveals an amazing blend of experiences and advice, featuring discussions of early investment, oncology, micromanagement, addiction, ChatGPT, and obesity. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Juergen Reess: Clinical Neurologist, Founding a Biotech & Leadership
Season 1 · Episode 6
Friday, March 14, 2025 • Duration 28:03
In this episode, we sit down with Dr. Juergen Reess, a Board-Certified Neurologist with an incredible career spanning over 20 years in corporate and drug development leadership roles at Boehringer Ingelheim. After an extensive career in big pharma, Juergen transitioned into the world of biotech, where he now plays a pivotal role in shaping the future of medicine.
Juergen is the Founder & CEO of MoglingBio Inc, an innovative company in the longevity space, pioneering novel pharmacological approaches to rejuvenate old stem cells, a field with immense potential. As well as this, Juergen is also the Fractional CMO of SciRhom, a Munich-based clinical-stage biotech tackling autoimmune diseases with iRhom2-targeting therapies, where they have just secured a €63M Series A funding round to propel their groundbreaking work.
In this insightful conversation, we explore, how Juergen kick-started his career in life sciences, how he kept his career "fresh" in a big pharma setting by taking on new challenges, the challenges and adaptions from transitioning from big pharma to biotech, lessons from founding and funding his own biotech ventures, what "Longevity" really means in the biotech world, how he adapts across various therapeutic areas and much more.
This episode is packed with valuable insights for anyone in life sciences, whether you're a scientist, entrepreneur, investor, or industry leader. Don't miss this inspiring discussion on innovation, adaptability, and leadership in biotech!
Brian Kim: Innovation & AI in Dermatology & Immunology
Season 2 · Episode 7
Friday, April 25, 2025 • Duration 55:18
In this episode, we sit down with Dr. Brian Kim, a true trailblazer at the cutting edge of science and medicine:
Co-Founder at Alys Pharmaceuticals, a biopharmaceutical company with an innovation focus on immuno-dermatology, redefining how we understand chronic itch and skin inflammation. Brian is also the Director of the Mark Lebwohl Center for Neuroinflammation and Sensation and the Allen Discovery Center for Neuroimmune Interactions.
Sol and Clara Kest Professor and Vice Chair of Research in Dermatology at Icahn School of Medicine at Mount Sinai.
Nearly two decades of experience spanning dermatology, immunology, allergy and neuroscience.
Internationally recognised for unlocking the mysteries of itch biology, opening doors to entirely new therapeutic approaches.
Previously the Co-Founder of Nuogen Pharma and now on the scientific advisory board for Attovia Therapeutics and Triveni Bio. Brian is also an advisor for Septerna - helping to translate scientific insights into next-generation therapies.
Recent keynote speaker at the prestigious Friedman Brain Institute’s Neuroscience Retreat, as well as plenary talks across both allergy and dermatology like the American Academy of Allergy, Asthma, and Immunology (AAAAI) Presidential Plenary Session (2/23/2024) and the Marion B. Sulzberger, MD Memorial Award and Lectureship at the American Academy of Dermatology March of 2024 - proving how his work resonates across disciplines.
In this episode, we discuss everything from Innovation & AI in dermatology to Leadership in Academia vs Industry. Brian also reveals the reason Dermatology is securing so much funding in 2025. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Frank Watanabe: Dermatology - Self Improvement, Growth & Leadership
Season 2 · Episode 9
Thursday, May 15, 2025 • Duration 40:06
In this episode, we sit down with Dr. Frank Watanabe, a titan of biotech and pharma, and leader shaping the future of medicine:
CEO of Arcutis Biotherapeutics, one of the few commercial stage Dermatology focused Biopharma companies; leading them from startup to IPO to commercial success.
25+ years in biotech and pharma with expertise across of various Therapeutic areas.
Proven leader in life sciences, known for building and scaling companies from early-stage to FDA approval - with leadership forged from time spent in the U.S. Navy.
Former roles at Kythera, Lilly Amgen, and Allergan - driving strategy, R&D, and game-changing product launches.
Champion of innovation, access, and purpose-driven leadership across the biopharma ecosystem
In this episode, we discuss everything from How Frank built Arcutis, motivation and Self-Improvement that is grounded from his experience in the Navy, revealing the key to success as a leader in the industry. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Volker Koscielny: Functionality and Success Behaviours in Leadership
Season 2 · Episode 8
Tuesday, May 6, 2025 • Duration 26:38
In this episode, we sit down with Dr. Volker Koscielny, a distinguished figure in the pharmaceutical industry, with a wealth of experience and a forward thinking approach to medical innovation:
CMO at Almirall, a global pharmaceutical company specialising in medical dermatology, dedicated to developing innovative treatments for skin diseases.
20+ years of experience in dermatology, bridging between R&D, business development, marketing, and sales.
Recognised globally for his commitment to understanding patient needs and demonstrating the real-world value of medicines.
Former roles at Celgene, GlaxoSmithKline, Pfizer, Servier and Boehringer Ingelheim, leaving Volker with the experience to lead and scale cross-functional teams ensures the seamless integration of regulatory, clinical, and commercial strategies.
Volker recently contributed to Almirall’s 15th annual Skin Academy, a conference that brings together dermatologists from across Europe to discuss advancements in inflammatory skin diseases and patient well-being.
In this episode, we discuss the future of dermatology, Volker’s insights from industry roundtables, and the key experiences and achievements that shaped his success in the field. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
In this episode, we sit down with Dr. Bernardo Cervantes, leading the charge in microbiome science, with a mix of experience and insights:
Bernardo is the Co-Founder and COO of Concerto Biosciences, a biotech pioneering the development of microbial consortia-based therapeutics.
With a robust background in microbial engineering, Bernardo has dedicated his career to studying microbial interactions and microbiome health. His expertise spans sythetic biology and metabolic engineering.
Bernardo is internationally recognised for his contributions to microbiome science, particularly in translating complex microbial ecology into practical applications. His work at Concerto Biosciences has positioned him as a thought leader in developing next-generation microbial therapeutics.
Prior to co-founding Concerto Biosciences, Bernardo earned his PhD in Microbiology from the Massachusetts Institute of Technology (MIT).
Concerto has been active at major scientific conferences, including the 2024 BIO International Convention, where Concerto Biosciences was featured in the NIH Innovation Zone.
In this episode, we discuss the future of microbiome sciences, Bernardo’s key learnings throughout his career, how he’s adapted his leadership as one of three Co-Founders, management, a great opportunity within the market and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Discover shows related to Leading Beyond The Lab, based on actual content similarities. Explore podcasts with similar topics, themes, and formats, backed by real data.
